Adam Golebiowski

5PUBLICATIONS

41CO-AUTHORS

Molecular targetsBiologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)Cheminformatics and quantitative structure-activity relationships

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|May 06, 2026

Structure-Guided Discovery of OAT-4828 as Potent, Selective, and Orally Bioavailable USP7 Inhibitor with <i>In Vivo</i> Antileukemic Activity.

|Mar 20, 2023

Arginase 1/2 Inhibitor OATD-02: From Discovery to First-in-man Setup in Cancer Immunotherapy.

Bartlomiej Borek, Julita Nowicka, Anna Gzik

|Oct 20, 2020

Discovery of <b>OATD-01</b>, a First-in-Class Chitinase Inhibitor as Potential New Therapeutics for Idiopathic Pulmonary Fibrosis.

Robert Koralewski, Barbara Dymek, Marzena Mazur

|Jul 11, 2019

Development of Dual Chitinase Inhibitors as Potential New Treatment for Respiratory System Diseases.

Marzena Mazur, Barbara Dymek, Robert Koralewski

|Dec 29, 2017

Targeting Acidic Mammalian chitinase Is Effective in Animal Model of Asthma.

Marzena Mazur, Jacek Olczak, Sylwia Olejniczak

Pageof 1

Frequent Collaborators

Jacek Olczak

Michał Piotrowicz

Marcin Nowotny

Bartlomiej Borek

Roman Blaszczyk

Jacek Chrzanowski

Julita Nowicka

Anna Gzik

Sebastian Glatt

Karol Jedrzejczak

Frequent Collaborators

Jacek Olczak

Michał Piotrowicz

Marcin Nowotny

Bartlomiej Borek